ChitoTech was developed from a research facility for studying marine biopolymers and their applications in medicine. The manufacturing site of the company established in 2004. ChitoTech activities are based on cutting edge technologies, producing advanced wound care, hemostatic products and colloidal silver antiseptic. Products in ChitoTech have the approval of Iranian Ministry of Health as well as CE, ISO13485 certificates. Our technology is protected by 5 European and 22 National patents. ChitoTech wound care products are suitable for a wide range of ulcers and burn wounds, hemostatic products are in different forms and are suitable for stopping venous and arterial bleedings and SilvoSept antiseptic solutions are a novel class of non-alcoholic antiseptics using colloidal silver technology. ChitoTech aims to offer consumers and healthcare systems safe, high quality and non-invasive.